[Federal Register Volume 81, Number 92 (Thursday, May 12, 2016)]
[Notices]
[Pages 29567-29568]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11141]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH), Docket Number CDC-2016-0036; 
NIOSH 248-E

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Time and Date: 9:00 a.m.-5:00 p.m., June 2, 2016 (All times are 
Eastern Daylight Time).
    Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New 
York, New York 10278. This meeting will also be available by telephone 
and Web conference. Audio only will be available by telephone; video 
will be available by Web conference. The USA toll-free, dial-in number 
is 1-888-606-8411, and when prompted enter passcode--5064451. To view 
the web conference, enter the following web address in your web 
browser: https://odniosh.adobeconnect.com/wtchpstac/.
    Public Comment Time and Date: 9:20 a.m.-9:50 a.m., June 2, 2016.
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up by 
providing their name by mail, email, or telephone, at the addresses 
provided below by May 29, 2016. Each commenter will be provided up to 
five minutes for comment. A limited number of time slots are available 
and will be assigned on a first come-first served basis. Written 
comments will also be accepted from those unable to attend the public 
session.
    Status: Open to the public, limited only by the number of telephone 
lines. The conference line will accommodate up to 50 callers; therefore 
it is suggested that those interested in calling in to listen to the 
committee meeting share a line when possible.
    Background: The Advisory Committee was established by Title I of 
the James Zadroga 9/11 Health and Compensation Act of 2010, Public Law 
111-347 (January 2, 2011), amended by Public Law 114-113 (Dec. 18, 
2015), adding Title XXXIII to the Public Health Service (PHS) Act 
(codified at 42 U.S.C. 300mm to 300mm-61).
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional WTC 
Health Program eligibility criteria, potential additions to the list of 
covered WTC-related health conditions, and research regarding certain 
health conditions related to the September 11, 2001 terrorist attacks. 
Title XXXIII of the PHS Act established the WTC Health Program within 
the Department of Health and Human Services (HHS). The WTC Health 
Program provides medical monitoring and treatment benefits to eligible 
firefighters and related personnel, law enforcement officers, and 
rescue, recovery, and cleanup workers who responded to the September 
11, 2001, terrorist attacks in New York City, at the Pentagon, and in 
Shanksville, Pennsylvania (responders), and to eligible persons who 
were present in the dust or dust cloud on September 11, 2001 or who 
worked, resided, or attended school, childcare, or adult daycare in the 
New York City disaster area (survivors). Certain specific activities of 
the WTC Program Administrator are reserved to the Secretary, HHS, to 
delegate at her discretion; other WTC Program Administrator duties not 
explicitly reserved to the Secretary, HHS, are assigned to the 
Director, NIOSH. The administration of the Advisory Committee is left 
to the Director of NIOSH in his role as WTC Program Administrator. CDC 
and NIOSH provide funding, staffing, and administrative support 
services for the Advisory Committee. The charter was reissued on May 
12, 2015, and will expire on May 12, 2017.
    Matters for Discussion: The Advisory Committee will address the new 
responsibilities required under the reauthorization of the WTC Health 
Program in the PHS Act. Specifically, the enhanced role of the STAC to 
(1) make recommendations regarding the identification of individuals to 
conduct independent peer reviews of the evidence that would be the 
basis for issuing final rules to add a health condition to the List of 
WTC-Related Health Conditions; and (2) review and evaluate the policies 
and procedures in effect within the WTC Health Program that are used to 
determine whether sufficient evidence is available to support adding a 
non-cancer condition or type of cancer to the List of WTC-Related 
Health Conditions.
    The two policies can be found at: http://www.cdc.gov/wtc/policies.html. The agenda will include presentations on peer review and 
the policies and procedures the WTC Health Program uses to add health 
conditions to the list of covered conditions.
    The agenda is subject to change as priorities dictate.
    To view the notice, visit http://www.regulations.gov and enter CDC-
2016-0036 in the search field and click ``Search.''
    Public Comment Sign-up and Submissions to the Docket: To sign up to 
provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS C-34, 
1090 Tusculum Avenue, Cincinnati, Ohio 45226.
    Email: [email protected].
    Telephone: (513) 533-8611.
    In the event an individual cannot attend, written comments may be 
submitted. The comments should be

[[Page 29568]]

limited to two pages and submitted through http://www.regulations.gov 
enter CDC-2016-0036 in the search field and click ``Search'' by May 29, 
2016. Efforts will be made to provide the two-page written comments 
received by the deadline above to the committee members before the 
meeting. Comments in excess of two pages will be made publicly 
available at http://www.regulations.gov (enter CDC-2016-0036 in the 
search field and click ``Search'').
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to http://www.regulations.gov (enter CDC-2016-0036 in the search field and click 
``Search'') within 60 days after the meeting. If a person making a 
comment gives his or her name, no attempt will be made to redact that 
name. NIOSH will take reasonable steps to ensure that individuals 
making public comments are aware of the fact that their comments 
(including their name, if provided) will appear in a transcript of the 
meeting posted on a public Web site. Such reasonable steps include a 
statement read at the start of the meeting stating that transcripts 
will be posted and names of speakers will not be redacted. If 
individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations in accordance with the Freedom 
of Information Act and, if deemed appropriate, will redact such 
information. Disclosures of information concerning third party medical 
information will be redacted.
    Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail 
Stop E-20, Atlanta, Georgia 30345, telephone 1 (888) 982-4748; email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-11141 Filed 5-11-16; 8:45 am]
 BILLING CODE 4163-18-P